Allspring Global Investments
EDIT icon

Allspring Global Investments’s Editas Medicine EDIT Stock Holding History

Allspring Global Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,046
Closed -$27.1K – 1654
2025
Q2 		$27.1K Sell
12,046
-23,735
-66% -$38.8K ﹤0.01% 1598
2025
Q1 		$40.4K Buy
35,781
+11,252
+46% +$16.6K ﹤0.01% 1710
2024
Q4 		$32.1K Buy
24,529
+44
+0.2% +$112 ﹤0.01% 1717
2024
Q3 		$83.5K Buy
24,485
+4,089
+20% +$17.8K ﹤0.01% 1803
2024
Q2 		$95.2K Buy
+20,396
New +$115K ﹤0.01% 1857
2023
Q3 		– Sell
-1,103
Closed -$9.08K – 2812
2023
Q2 		$9.08K Sell
1,103
-3,347
-75% -$29.2K ﹤0.01% 2544
2023
Q1 		$32.3K Buy
4,450
+2,599
+140% +$23.1K ﹤0.01% 2404
2022
Q4 		$16.4K Sell
1,851
-41
-2% -$450 ﹤0.01% 2627
2022
Q3 		$23K Hold
1,892
– – ﹤0.01% 2589
2022
Q2 		$22K Sell
1,892
-28,570
-94% -$383K ﹤0.01% 2462
2022
Q1 		$579K Sell
30,462
-1,499
-5% -$27.9K ﹤0.01% 2159
2021
Q4 		$848K Buy
+31,961
New +$1.1M ﹤0.01% 2035

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Allspring Global Investments's EDIT Position: Q3 2025 in Review

Allspring Global Investments sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 12,046 shares — an estimated $27.1K sold.

Allspring Global Investments first reported a position in EDIT in Q4 2021 and held it in 12 quarters. The position peaked at $848K in Q4 2021. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Allspring Global Investments reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • Allspring Global Investments sold 12,046 Editas Medicine shares in Q3 2025, an estimated $27.1K.
  • Allspring Global Investments first reported a position in Editas Medicine in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Editas Medicine position peaked at $848K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Allspring Global Investments's 13F filing for Q3 2025, filed 20 Oct 2025.